Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Frontiers in Immunology|June 25, 2019
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Paula M Vertino, et al.Molecular Cancer Research : MCR|April 5, 2022
PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and SurvivalTyler Moser-Katz, Catherine M Gavile, Benjamin G Barwick, et al.Nucleic Acids Research|December 2, 2016
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myelomaDongxue Wang, Hideharu Hashimoto, Xing Zhang, et al.Blood Advances|January 4, 2018
CD86 regulates myeloma cell survivalCatherine M Gavile, Benjamin G Barwick, Scott Newman, et al.Blood Cancer Journal|December 15, 2020
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myelomaYanyan Gu, Benjamin G Barwick, Mala Shanmugam, et al.Seminars in Oncology|October 19, 2013
The future of drug development and therapy in myelomaSagar Lonial, Lawrence H BoiseCancer Research|May 3, 2019
Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple MyelomaLawrence H Boise, Mala ShanmugamOncology (Williston Park, N.Y.)|September 5, 2014
Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaSagar Lonial, Lawrence H BoiseAutophagy|January 19, 2011
Farnesyl transferase inhibitors, autophagy, and proteasome inhibition: synergy for all the right reasonsSagar Lonial, Lawrence H BoisePageof 15